Fig. 3From: Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft modelsRepresentative images of 18F-FMISO ARG (a), pimonidazole IHC (b), H&E staining (c), quantitative analysis of intratumoral 18F-FMISO accumulation level (d), and %pimonidazole-positive area (e) in the ex vivo study groupsBack to article page